Literature DB >> 18005458

Vulvodynia: new thoughts on a devastating condition.

Jennifer Gunter1.   

Abstract

UNLABELLED: Vulvodynia affects 3% to 15% of women; many suffer through years of misdiagnosis and for those who receive care cures are uncommon. Little is known about the etiology and a wide range of therapeutic options are available. With treatment approximately 50% of women will report sustained improvement in pain scores of 50% or more, however, reasons for varied response rates are yet unknown. This article will explore 3 factors that may contribute to inconsistent results with therapy; the hypothesis that vulvodynia is a systemic disorder; the idea that failure to address the psychological or emotional aspect or chronic pain may affect outcome; and the concept that chronic vulvar pain, like headache, is not a single condition but is a diverse group of disorders that produce the same symptom. TARGET AUDIENCE: Obstetricians & Gynecologists, Family Physicians LEARNING
OBJECTIVES: After completion of this article, the reader should be able to state that vulvodynia is a complex disorder, explain that no one treatment is superior, relate that pathophysiology is important, and recall that psychological aspects of chronic pain must be appreciated.

Entities:  

Mesh:

Year:  2007        PMID: 18005458     DOI: 10.1097/01.ogx.0000290350.14036.d6

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  6 in total

1.  Is chronic stress during childhood associated with adult-onset vulvodynia?

Authors:  Maheruh Khandker; Sonya S Brady; Elizabeth G Stewart; Bernard L Harlow
Journal:  J Womens Health (Larchmt)       Date:  2014-07-21       Impact factor: 2.681

2.  The influence of depression and anxiety on risk of adult onset vulvodynia.

Authors:  Maheruh Khandker; Sonya S Brady; Allison F Vitonis; Richard F Maclehose; Elizabeth G Stewart; Bernard L Harlow
Journal:  J Womens Health (Larchmt)       Date:  2011-08-08       Impact factor: 2.681

3.  Altered central sensitization in subgroups of women with vulvodynia.

Authors:  Zheng Zhang; Denniz A Zolnoun; Eric M Francisco; Jameson K Holden; Robert G Dennis; Mark Tommerdahl
Journal:  Clin J Pain       Date:  2011 Nov-Dec       Impact factor: 3.442

4.  Open-label trial of lamotrigine focusing on efficacy in vulvodynia.

Authors:  Samantha E Meltzer-Brody; Denniz Zolnoun; John F Steege; Katherine L Rinaldi; Jane Leserman
Journal:  J Reprod Med       Date:  2009-03       Impact factor: 0.142

Review 5.  Recent advances in understanding provoked vestibulodynia.

Authors:  Ahinoam Lev-Sagie; Steven S Witkin
Journal:  F1000Res       Date:  2016-10-26

Review 6.  Immunological and genetic characterization of women with vulvodynia.

Authors:  Stefan Gerber; Steven S Witkin; David Stucki
Journal:  J Med Life       Date:  2008 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.